KRT1 and melanoma: In conclusion, our study is the first to demonstrate that KRT1/2/5/6/8/10/14/15/16/17 expression is elevated in primary melanoma compared with metastatic, and that high KRT1/5/6/14/15/16/17 mRNA levels predict poor prognosis.